Pixantrone
Back to searchMolecule Structure
Scientific Name
Pixantrone
Description of the Drug
Pixantrone is an antineoplastic agent use to treat patients with relapsed or refractory aggressive Non-Hodgkin B-cell Lymphomas (NHL).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06193
http://www.drugbank.ca/drugs/DB06193
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | CROSS-LINKING AGENT | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7825 |
| Human Metabolome Database | HMDB0256621 |
| DrugBank | DB06193 |
| PubChem: Thomson Pharma | 14801640 |
| PubChem | 134019 |
| Nikkaji | J580.321G |
| EPA CompTox Dashboard | DTXSID10162744 |
| DrugCentral | 4330 |
| ChemicalBook | CB71321822 |
| Guide to Pharmacology | 7544 |
| ChEBI | 135945 |
| ZINC | ZINC000001535903 |
